Insilico Medicine appoints Sujata Rao, M.D., as Senior Vice President to oversee clinical development
Scienmag
JULY 19, 2022
Social & Behavioral Science appoints clinical development Insilico M.D
Clinical Development Related Topics 
73 
Future of clinical development highlighted in online event
Outsourcing Pharma
APRIL 7, 2022
Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances. Clinical Development
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Rivus raises $132m to advance clinical development of obesity treatment
Pharmaceutical Technology
SEPTEMBER 23, 2022
Rivus Pharmaceuticals has raised $132m in a Series B funding round to clinically advance its lead candidate, HU6, for the treatment of obesity and cardio-metabolic disorders.
Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development
Outsourcing Pharma
SEPTEMBER 7, 2022
The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company. Clinical Development
Navigating the challenges of proper fill and finish in clinical development
Bio Pharma Dive
FEBRUARY 1, 2021
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance
Ukraine war dramatically impacting global clinical development: Phesi
Outsourcing Pharma
MARCH 24, 2022
The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders. Clinical Development
Nimbus Therapeutics Strengthens Clinical Development Leadership Team
BioTech 365
APRIL 13, 2022
Nimbus Therapeutics Strengthens Clinical Development Leadership Team Nimbus Therapeutics Strengthens Clinical Development Leadership Team CAMBRIDGE, Mass.–(BUSINESS
Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
BioTech 365
JULY 21, 2022
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development 21.07.2022 / 09:00 The issuer is solely responsible for the content of this announcement.
Samsung Biologics to help Enzolytics advance clinical development of mAbs
BioPharma Reporter
OCTOBER 11, 2021
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing
Adverum Down After Clinical Development Shift for Gene Therapy Program
BioSpace
JULY 22, 2021
Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME
Biophytis provides updates on Sarconeos (BIO101) clinical development
BioTech 365
APRIL 6, 2022
Biophytis / Key word(s): Miscellaneous Biophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CEST Biophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program … Continue reading → EQS Newsfeed
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations
BioTech 365
MAY 11, 2022
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations BEIJING & CAMBRIDGE, Mass.–(BUSINESS
Brii Biosciences Provides Update on Strategic Clinical Development Progress
BioTech 365
MAY 17, 2021
Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S.
|
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan
BioTech 365
FEBRUARY 11, 2022
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitis Sufficient capital to complete Phase 2 IBD … Continue reading → GlobeNewswire
Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease
BioTech 365
MARCH 22, 2022
Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease – Single pivotal trial to initiate later this month targets the broad patient population … Continue reading → Business Wire
ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform
BioTech 365
JUNE 17, 2022
ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform ZAIDYN Clinical Development empowers life sciences companies to break down silos in clinical trial design and planning, remove … Continue reading → Business Wire
AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01
BioTech 365
DECEMBER 15, 2020
Novavax Announces COVID-19 Vaccine Clinical Development Progress
The Pharma Data
NOVEMBER 30, 2020
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K.
Shasqi Appoints Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as SVP of Clinical Development
BioTech 365
MAY 24, 2022
MBA, as SVP of Clinical Development Shasqi Appoints Steve Abella, M.D., MBA, as SVP of Clinical Development – Appointments … Continue reading → Business WireShasqi Appoints Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D.,
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease
BioTech 365
DECEMBER 16, 2021
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease CTA approved by Health Canada in November 2021; … Continue reading → Business Wire
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
BioTech 365
NOVEMBER 10, 2021
Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
BioTech 365
MAY 12, 2022
Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights On Track to Meet Multiple Clinical Milestones for AU-011 in … Continue reading → Business Wire
Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership
BioTech 365
SEPTEMBER 29, 2021
Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development
BioTech 365
MARCH 30, 2022
Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Successful IPO on Euronext Growth® in Paris Cash … Continue reading → Business Wire
Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225
BioTech 365
JULY 6, 2022
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225 06.07.2022 / 09:13 The issuer is solely responsible for the content of … Continue reading → EQS Newsfeed
Bayer taps Clariness to build patient insights into clinical trial review process
Outsourcing Pharma
SEPTEMBER 13, 2022
Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback. Clinical Development
Bayer Starts Phase III Clinical Development Program OASIS With Investigational Product, Elinzanetant
BioTech 365
AUGUST 31, 2021
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments
BioTech 365
AUGUST 17, 2021
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
BioTech 365
AUGUST 10, 2021
Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology
BioTech 365
JULY 29, 2021
AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01
The Pharma Data
DECEMBER 14, 2020
AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC.
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development
BioTech 365
JULY 13, 2021
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
BioTech 365
FEBRUARY 10, 2022
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines — Curevo’s lead program is CRV-101, … Continue reading → Business Wire
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
BioTech 365
MARCH 23, 2022
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Announced positive topline data from EQUATE … Continue reading → Business Wire
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
BioTech 365
JULY 1, 2021
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D.,
Human element important for decentralized trial advancement
Outsourcing Pharma
JULY 25, 2022
Clinical DevelopmentDuring the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.
Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International Convention, June 13 – 16, 2022, San Diego, CA
BioTech 365
JUNE 8, 2022
Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International Convention, June 13 – 16, 2022, San Diego, CA Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International Convention, … Continue reading → Business Wire
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
BioTech 365
JUNE 6, 2022
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at … Continue reading → Business Wire
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
BioTech 365
JUNE 6, 2022
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at … Continue reading → Business Wire
Let's personalize your content